In recent years, the term PCOS (Polycystic Ovary Syndrome) has been officially renamed PMOS (Polycystic Metabolic Ovary Syndrome) by a coalition of 56 organizations. This change aims to underscore the tight connection between this condition and metabolic health.
Globally, approximately 170 million women are affected by PMOS, with many cases remaining undiagnosed—estimates suggest that around 70% of women may be unaware they have the disorder. A staggering 85% of patients experience insulin resistance, which increases the risk of developing type 2 diabetes by a factor of four.
Impact of New Medications on Alzheimer’s Risk
Modern therapies are gaining prominence in managing conditions associated with PMOS. Recent research shows that SGLT2 inhibitors can reduce the risk of Alzheimer’s disease by 43%. Meanwhile, GLP-1 agonists contribute to a 33% reduction. As of May 22, 2026, the European Medicines Agency (EMA) has recommended approval for an oral Semaglutide tablet.
Micronutrient Deficiencies in Diabetes Patients
A recent meta-analysis published in BMJ Nutrition Prevention & Health highlights concerning statistics: 45% of type 2 diabetes patients suffer from general micronutrient deficiencies. Notably, vitamin D deficiency affects 60.5% of patients, while magnesium is lacking in 42%, and 28% experience iron deficiency. Additionally, long-term metformin therapy can hinder the absorption of vitamin B12.
Research indicates that lifestyle factors contribute 55% to the development of diabetes, while genetic factors account for approximately 45%. This dual influence underlines the importance of lifestyle management in PMOS.
Increased Nutrient Needs During Pregnancy
The transition from PCOS to PMOS emphasizes metabolic health, particularly regarding pregnancy. It’s crucial to note that 85% of affected women possess insulin resistance, often without awareness. The German Nutrition Society recommends pregnant women to increase their daily intake of folic acid (400 µg) and iodine (100 µg). Alarmingly, 86% of these women are deficient in folic acid, while 29.7% lack sufficient vitamin D.
Other essential nutrients for fetal development include calcium, DHA, iron, B vitamins, and magnesium. New research from Japan published in Spring 2026 raises alarms about frucotose-laden sweetened beverages during pregnancy, as they may adversely affect fetal brain development through epigenetic changes. Environmental factors also contribute, with exposure to PFAS chemicals increasing the risk of hormonal disorders in children by factors ranging from 2.3 to 2.7.
Bacterial Indicators of Diabetes Risk
Early detection of metabolic risks is improving significantly. A Swedish study conducted in 2026 identified nine bacterial species in gut flora that can signal an increased diabetes risk years in advance. Adopting a fiber-rich diet can help mitigate these risks.
The Role of Continuous Glucose Monitoring (CGM)
Recent studies further show that 45% of diabetes patients struggle with micronutrient deficiencies, particularly vitamin D and magnesium. For women with PMOS, adequate nutrient intake is essential. A free checklist featuring the five most critical nutrients is available to help manage these requirements effectively.
Longitudinal data from South Korea (2016-2022) indicates that continuous glucose monitoring (CGM) can reduce the risk of coronary heart disease by 72%, while overall mortality among users decreased by 62%. In June 2026, the FDA approved over-the-counter CGM systems for children as young as two, which is part of ongoing efforts in Germany to preserve essential treatment standards in medicine.
Disclaimer: This article does not constitute investment advice, nor does it recommend the buying or selling of any financial instruments. The information provided is subject to change and should not be considered reliable. Trading in financial markets may result in significant losses. Our articles are created with assistance from AI and undergo automated checks to ensure quality.
